Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 4
1993 1
1996 1
1997 1
1998 3
2000 1
2001 6
2002 4
2003 6
2004 7
2005 22
2006 13
2007 17
2008 15
2009 17
2010 25
2011 33
2012 47
2013 30
2014 40
2015 45
2016 33
2017 27
2018 28
2019 31
2020 18
2021 27
2022 27
2023 26
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

498 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Clopidogrel with or without omeprazole in coronary artery disease.
Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP; COGENT Investigators. Bhatt DL, et al. N Engl J Med. 2010 Nov 11;363(20):1909-17. doi: 10.1056/NEJMoa1007964. Epub 2010 Oct 6. N Engl J Med. 2010. PMID: 20925534 Free article. Clinical Trial.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.
[Hypoaldosteronism].
Krysiak R, Kedzia A, Krupej-Kedzierska J, Okopień B. Krysiak R, et al. Among authors: okopien b. Przegl Lek. 2013;70(2):69-75. Przegl Lek. 2013. PMID: 23879007 Review. Polish.
Inclisiran-A Revolutionary Addition to a Cholesterol-Lowering Therapy.
Dec A, Niemiec A, Wojciechowska E, Maligłówka M, Bułdak Ł, Bołdys A, Okopień B. Dec A, et al. Among authors: okopien b. Int J Mol Sci. 2023 Apr 6;24(7):6858. doi: 10.3390/ijms24076858. Int J Mol Sci. 2023. PMID: 37047830 Free PMC article. Review.
Insight into the Evolving Role of PCSK9.
Maligłówka M, Kosowski M, Hachuła M, Cyrnek M, Bułdak Ł, Basiak M, Bołdys A, Machnik G, Bułdak RJ, Okopień B. Maligłówka M, et al. Among authors: okopien b. Metabolites. 2022 Mar 17;12(3):256. doi: 10.3390/metabo12030256. Metabolites. 2022. PMID: 35323699 Free PMC article. Review.
Pleiotropic Effects of PCSK-9 Inhibitors.
Basiak M, Kosowski M, Cyrnek M, Bułdak Ł, Maligłówka M, Machnik G, Okopień B. Basiak M, et al. Among authors: okopien b. Int J Mol Sci. 2021 Mar 19;22(6):3144. doi: 10.3390/ijms22063144. Int J Mol Sci. 2021. PMID: 33808697 Free PMC article. Review.
[Postparum thyroiditis].
Krysiak R, Okopień B, Herman ZS. Krysiak R, et al. Among authors: okopien b. Pol Merkur Lekarski. 2006 Jun;20(120):721-6. Pol Merkur Lekarski. 2006. PMID: 17007279 Review. Polish.
498 results